Strong start of the year for Redcare Pharmacy, double-digit sales growth continues. Total sales growth 51% year over year to EUR 560M in Q1 and 19% excluding MediService. Non-Rx sales growth 20% to EUR 404M. Active customer base expanded to 11.2M, up 0.4M in Q1 and 1.5M year over year. Net promoter score remained unabatedly high around 70. Fi [ … ]

Successful completion of a record year for Redcare Pharmacy: growth 49%, adj. EBITDA margin up 3.7pp to 3%; guidance achieved in all its elements. Total Group sales EUR 1.8 bn, up 49% vs. prior year. Non-Rx sales EUR 1.3 bn, up 25% vs. prior year. Adj. EBITDA margin 3% for full year 2023, +3.7pp vs. 2022, with major improvements in both DACH an [ … ]

Seamless transition for continuity and stability: Redcare Pharmacy with internal succession plan for Stephan Weber (CCO) and Marc Fischer (CIO). Dirk Brüse and Lode Fastré, both long-standing managers at Redcare Pharmacy, are to succeed Stephan Weber and Marc Fischer as CCO and CIO. Board members and founders see the ideal time for the leadership [ … ]

Disclosure of inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014   Redcare Pharmacy with internal succession plan due to the early departure of CCO Stephan Weber and CIO Marc Fischer at the Annual General Meeting on 17 April 2024. Sevenum, 4 March 2024. The Supervisory Board of Redcare Pharmacy today has agreed to the e [ … ]

Another successful fast-growth quarter for Redcare Pharmacy, completing full year 2023 at the very upper end of its guidance.  Q4 total sales EUR 531M, year-over-year growth 62%, excluding MediService 23%. Full year total sales EUR 1.8bn vs. guidance of EUR 1.7-1.8bn, a growth of 49%. Excluding MediService, growth was 24%. Non-Rx sales grew 23%  [ … ]